SGLT2 inhibitors associated with increased risk of lower-limb amputation in new study

SGLT2 inhibitors may be linked to a doubling in the risks of lower-limb amputation and diabetic ketoacidosis compared with GLP-1 receptor agonists, according to a new study.

by Yejin Yang
SGLT2 inhibitors may increase the risk of lower-limb amputation. | B. BOISSONNET/ SCIENCE PHOTO LIBRARY
SGLT2 inhibitors may increase the risk of lower-limb amputation. | B. BOISSONNET/ SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package